The Metabolic Topography of Parkinsonism

[1]  S. Strother,et al.  Scaled Subprofile Model: A Statistical Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  K. Marder,et al.  An estimate of the incidence of dementia in idiopathic Parkinson's disease , 1990, Neurology.

[3]  A Parving,et al.  Potential Language and Attentional Networks Revealed through Factor Analysis of rCBF Data Measured with SPECT , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  P. Mcgeer,et al.  Cortical glucose metabolism in parkinson's and alzheimer's disease , 1990, Journal of neuroscience research.

[5]  W Fernandez,et al.  Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine , 1992, Annals of neurology.

[6]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[7]  A. Galaburda,et al.  Inferior parietal lobule. Divergent architectonic asymmetries in the human brain. , 1984, Archives of neurology.

[8]  A. Crane,et al.  Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  M. Mintun,et al.  Enhanced Detection of Focal Brain Responses Using Intersubject Averaging and Change-Distribution Analysis of Subtracted PET Images , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  D. Carpenter,et al.  Apparent discrepancy between single-unit activity and [14C]deoxyglucose labeling in optic tectum of the rattlesnake. , 1983, Journal of neurophysiology.

[11]  Karl J. Friston,et al.  Functional Connectivity: The Principal-Component Analysis of Large (PET) Data Sets , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  K P Offord,et al.  Epidemiology of parkinsonism: Incidence, classification, and mortality , 1984, Annals of neurology.

[13]  J. Haxby,et al.  Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's Disease , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  D Comar,et al.  Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[15]  M. Mesulam.  A cortical network for directed attention and unilateral neglect , 1981, Annals of neurology.

[16]  I. Mitchell,et al.  Regional brain uptake of 2-deoxyglucose in N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkey , 1985, Neuropharmacology.

[17]  David Eidelberg,et al.  Superpett 3000 time-of-flight PET tomograph: optimization of factors affecting quantitation , 1993 .

[18]  Marcus E. Raichle,et al.  Regional blood flow in herniparkinsonism , 1985, Neurology.

[19]  J C Mazziotta,et al.  Somatotopic mapping of the primary motor cortex in humans: activation studies with cerebral blood flow and positron emission tomography. , 1991, Journal of neurophysiology.

[20]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[21]  I. Mitchell,et al.  A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. , 1992, Brain : a journal of neurology.

[22]  J R Moeller,et al.  The metabolic anatomy of paraneoplastic cerebellar degeneration , 1988, Annals of neurology.

[23]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[24]  R D ADAMS,et al.  STRIATO-NIGRAL DEGENERATION. , 1964, Journal of neuropathology and experimental neurology.

[25]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[26]  D. Eidelberg.  Positron emission tomography studies in parkinsonism. , 1992, Neurologic clinics.

[27]  Richard S. J. Frackowiak,et al.  Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study , 1992, Annals of neurology.

[28]  R. Watts,et al.  The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. , 1992, Neurologic clinics.

[29]  H. Johnson,et al.  A comparison of 'traditional' and multimedia information systems development practices , 2003, Inf. Softw. Technol..

[30]  V. Dhawan,et al.  Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  G. Sawle.  The detection of preclinical Parkinson's disease: What is the role of positron emission tomography? , 1993, Movement disorders : official journal of the Movement Disorder Society.

[32]  A. Galaburda,et al.  Topographical variation of the human primary cortices: implications for neuroimaging, brain mapping, and neurobiology. , 1993, Cerebral cortex.

[33]  D. Margouleff,et al.  Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease , 1993, Annals of neurology.

[34]  A. Crane,et al.  Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M Otsuka,et al.  Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[36]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  John F. Marshall,et al.  Plasticity of [14C]2-deoxy-d-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement , 1980, Brain Research.

[38]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.

[39]  J R Moeller,et al.  The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[40]  J R Moeller,et al.  A Regional Covariance Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[42]  R. C. Collins,et al.  Metabolic effects of unilateral lesion of the substantia nigra , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  Alan C. Evans,et al.  Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  J. Haxby,et al.  Positron emission tomography in Alzheimer's disease , 1986, Neurology.

[45]  T. Hattori,et al.  MPTP neurotoxicity to cerebellar Purkinje cells in mice , 1993, Neuroscience Letters.

[46]  R Harrop,et al.  Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[47]  A. Lees,et al.  Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.

[48]  Nir Giladi,et al.  Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome. , 1993, Advances in neurology.

[49]  Thomas Chaly,et al.  A large scale manual production of [18F]FDG using a synthetic unit made of sterile disposable components and operated by a master slave manipulator , 1990 .

[50]  J R Moeller,et al.  Effects of Percent Thresholding on the Extraction of [18F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  W. Gibb.  Neuropathology of Parkinson's disease and related syndromes. , 1992, Neurologic clinics.

[52]  David Eidelberg,et al.  Imaging cerebral function , 1993, IEEE Computer Graphics and Applications.

[53]  J R Moeller,et al.  The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies , 1990, Movement disorders : official journal of the Movement Disorder Society.

[54]  J. Haxby,et al.  Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[55]  Donald B. Rubin,et al.  Multiple Contrasts and Ordered Bonferroni Procedures , 1984 .

[56]  W. L. Clark.  Pithecanthropus in Peking , 1945 .

[57]  S. Strother,et al.  The metabolic pathology of the AIDS dementia complex , 1987, Annals of neurology.

[58]  K J Kearfott,et al.  A new headholder for PET, CT, and NMR imaging. , 1984, Journal of computer assisted tomography.

[59]  D J Brooks,et al.  Detection of preclinical Parkinson's disease with PET , 1991, Neurology.

[60]  L. Mansi,et al.  CORTICAL ABNORMALITIES IN ALZHEIMER'S DISEASE , 1984, Annals of neurology.

[61]  A. Bol,et al.  Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration , 1989, Annals of neurology.

[62]  A. Crossman,et al.  A hypothesis on the pathophysiological mechanisms that underlie levodopa‐ or dopamine agonist‐induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment , 1990, Movement disorders : official journal of the Movement Disorder Society.

[63]  T Jones,et al.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.

[64]  T. W. Anderson.  An Introduction to Multivariate Statistical Analysis , 1959 .

[65]  M E Raichle,et al.  Regional blood flow in hemiparkinsonism. , 1985, Neurology.

[66]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. , 1990, Archives of general psychiatry.